Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation. (2016)
Attributed to:
Defining the role of ERK5 kinase and ERK5 transcriptional activities in cell migration and EMT using novel ERK5 inhibitors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/15384101.2015.1120915
PubMed Identifier: 26959608
Publication URI: http://europepmc.org/abstract/MED/26959608
Type: Journal Article/Review
Volume: 15
Parent Publication: Cell cycle (Georgetown, Tex.)
Issue: 4
ISSN: 1551-4005